Joint Providership Accreditation Statement:
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the USF Health Office of Continuing Professional Development and the Sentinel Node Oncology Foundation (SNOF). USF Health Office of Continuing Professional Development is accredited by the ACCME to provide continuing medical education for physicians.
The USF Health Office of Continuing Professional Development designates this live activity for a maximum of 1 AMA PRA Category 1 Credits™ on a one-hour credit for one hour of attendance basis to participating physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity is intended for physicians specializing in surgery, oncology, molecular imaging, plastic surgery, radiation oncology, hematology, thoracic medicine with the remainder a mixture of predominately PhD/scientists from both academia and biotechnology as well as a smaller groups of attendees who are in training.
- Describe cancer initiation and progression in the tumor microenvironment.
- Distinguish the pathways of metastasis by virtue of the lymphatic versus vascular systems.
- Recognize the utility of SLN biopsy in multiple cancers and that SLN may be the primary gateway to cancer metastasis.
- Discuss the application of immune check point inhibition to treat cancer.
- Describe and integrate new genetic and mutational analysis information as biomarkers for diagnoses, staging and treatment selection for patients with metastatic cancers.
- Describe the potential application of molecular imaging for pinpoint stereotactic radiotherapy.
- Identify secondary lymphedema resulting from cancer treatment and methods to overcome lymphedema.
The content for this activity was developed independently of the commercial supporters. All materials are included with permission. The opinions expressed are those of the faculty and are not to be construed as those of the publisher or grantors.
This educational activity was planned and produced in accordance with the ACCME Accreditation Criteria, Policies, and Standards for Commercial Support. Recommendations involving clinical medicine in a continuing medical education (CME/CE) activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported, or used in CME/CE in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection, and analysis.
This CME/CE activity might describe the off-label, investigational, or experimental use of medications that may exceed their FDA-approved labeling. Physicians should consult the current manufacturers’ prescribing information for these products. The Organizers requires the speakers to disclose that a product is not labeled for the use under discussion.
REGISTERED NURSES: For the purpose of re-certification, the American Nurses Credentialing Center (ANCC) accepts AMA PRA Category 1 Credits™ issued by organizations accredited by the ACCME.
The Organizers require that the faculty participating in a CME/CE activity disclose all affiliations or other financial relationships (1) with the manufacturers of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation and (2) with any commercial supporters of the activity. All conflicts of interest have been resolved prior to this CME/CE activity.
Disclosure information will be provided by the speakers as part of their slide presentations.
Staff and Reviewer Disclosures
Staff members and others involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.
This activity is provided by: